These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38115302)
1. The prognostic value of Forkhead box P3 regulatory T cells in biliary tract cancer: A systematic review and meta-analysis. Cai P; Wu Z; Yang X; Wang N; Yang Y Medicine (Baltimore); 2023 Dec; 102(50):e36608. PubMed ID: 38115302 [TBL] [Abstract][Full Text] [Related]
2. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis. Shou J; Zhang Z; Lai Y; Chen Z; Huang J BMC Cancer; 2016 Aug; 16(1):687. PubMed ID: 27566250 [TBL] [Abstract][Full Text] [Related]
3. Prognostic roles of leptin-signaling proteins, PD-L1, and tumor-infiltrating lymphocytes in surgically-resected biliary tract cancers. Byeon SJ; Chang MS; Cho HJ; Park JH; Kim KH; Park JH; Choi IS; Kim W; Han DS; Ahn HS; Heo SC J Surg Oncol; 2023 Mar; 127(4):587-597. PubMed ID: 36367404 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of FOXP3 Bai Y; He T; Zhang L; Liu Q; Yang J; Zhao Z; Yang K; Zhang M BMJ Open; 2022 Sep; 12(9):e060659. PubMed ID: 36691128 [TBL] [Abstract][Full Text] [Related]
5. The Clinicopathological and Prognostic Implications of FoxP3 Xu P; Fan W; Zhang Z; Wang J; Wang P; Li Y; Yu M Front Physiol; 2017; 8():950. PubMed ID: 29209232 [No Abstract] [Full Text] [Related]
6. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis. Lin SC; Gan ZH; Yao Y; Min da L PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Shang B; Liu Y; Jiang SJ; Liu Y Sci Rep; 2015 Oct; 5():15179. PubMed ID: 26462617 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis. Xian F; Ren D; Bie J; Xu G Front Immunol; 2023; 14():1119168. PubMed ID: 37138876 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078 [TBL] [Abstract][Full Text] [Related]
11. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. Alvisi G; Termanini A; Soldani C; Portale F; Carriero R; Pilipow K; Costa G; Polidoro M; Franceschini B; Malenica I; Puccio S; Lise V; Galletti G; Zanon V; Colombo FS; De Simone G; Tufano M; Aghemo A; Di Tommaso L; Peano C; Cibella J; Iannacone M; Roychoudhuri R; Manzo T; Donadon M; Torzilli G; Kunderfranco P; Di Mitri D; Lugli E; Lleo A J Hepatol; 2022 Nov; 77(5):1359-1372. PubMed ID: 35738508 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study. Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194 [TBL] [Abstract][Full Text] [Related]
13. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835 [TBL] [Abstract][Full Text] [Related]
14. The prognostic values of FOXP3 Sun Y; Wang Y; Lu F; Zhao X; Nie Z; He B Clin Transl Oncol; 2023 Jun; 25(6):1830-1843. PubMed ID: 36692642 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis. Song S; Yang W; Tian H; Gong S; Lei C; Lv K; Lu T; Cheng Q; Yang K; Guo T Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101788. PubMed ID: 34389530 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis. Hu L; Zhu M; Shen Y; Zhong Z; Wu B World J Surg Oncol; 2021 Oct; 19(1):300. PubMed ID: 34654443 [TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells, especially ICOS Tu JF; Ding YH; Ying XH; Wu FZ; Zhou XM; Zhang DK; Zou H; Ji JS Sci Rep; 2016 Oct; 6():35056. PubMed ID: 27725696 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis. Zhao S; Jiang T; Zhang L; Yang H; Liu X; Jia Y; Zhou C Oncotarget; 2016 Jun; 7(24):36065-36073. PubMed ID: 27153545 [TBL] [Abstract][Full Text] [Related]
19. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs. Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257 [TBL] [Abstract][Full Text] [Related]
20. Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer. Kim HD; Kim JH; Ryu YM; Kim D; Lee S; Shin J; Hong SM; Kim KH; Jung DH; Song GW; Hwang DW; Lee JH; Song KB; Ryoo BY; Jeong JH; Kim KP; Kim SY; Yoo C Cancer Res Treat; 2021 Jan; 53(1):162-171. PubMed ID: 32878426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]